Liberia has begun the first-ever large-scale Ebola vaccine trials

(Image credit: John Moore/Getty Images)

On Monday, Liberia began the first large-scale trials of two experimental Ebola vaccines. Scientists in Liberia plan to immunize 30,000 volunteers and healthcare workers with the new drugs.

The trial that began on Monday included injecting the volunteers with a strain of the Ebola virus to trick their bodies into developing immune responses. But scientists aren't sure whether the trial vaccines will be effective against Ebola. Monday's test involves 12 volunteers, and more volunteers will be given the vaccine as the trial continues.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us
Meghan DeMaria

Meghan DeMaria is a staff writer at TheWeek.com. She has previously worked for USA Today and Marie Claire.